PROTEIN ELICITING ABILITY FOR FORMATION OF C3-CONVERTASE, DNA, VECTOR, CONJUGATE AND THEIR USING Russian patent published in 2004 - IPC

Abstract RU 2238322 C2

FIELD: biotechnology, molecular biology, biochemistry, medicine.

SUBSTANCE: invention describes native proteins, ways for activation of complement modified by so manner that protein is able to form C3-convertase that is resistant to down-regulation. Preferably, the modified protein represents the modified human C3 protein. Also, invention describes both DNA sequences encoding such proteins and DNA constructions. Invention describes also conjugates comprising such proteins and binding specifically fragment, for example, antibody, and application of such proteins and/or conjugates in therapy also. Invention can be used for humans in vivo for activation of complement and to obtain a preparation that has no immunogenic properties for humans in it using.

EFFECT: valuable biological and medicinal properties of protein.

35 cl, 15 dwg, 3 tbl, 17 ex

Similar patents RU2238322C2

Title Year Author Number
HUMAN MODIFIED PROTEIN C3, DNA FRAGMENT, CONJUGATE, PHARMACEUTICAL COMPOSITION, METHOD OF DECREASE OF PROTEIN AMOUNT CONTENT 1995
  • Garrison Richard Aleksandr
  • Fehrriz Timoti Charl'Z
RU2194713C2
HUMANIZED ANTIBODY TO CONFORMATIONAL C3 EPITOPE CONSTITUENT OF HUMAN COMPLEMENT, DNA SEQUENCE (VERSIONS), EXPRESSION VECTOR CONTAINING DNA SEQUENCE (VERSIONS), AND OVARIAN CELLS' STRAIN OF CHINESE HAMSTER CHO-HUMC34-PRODUCER OF THIS HUMANIZED ANTIBODY 2016
  • Kartuzova Valeriya Evgenevna
  • Trofimov Aleksandr Viktorovich
  • Ishchenko Aleksandr Mitrofanovich
  • Rodin Sergej Vladimirovich
  • Zhakhov Aleksandr Vladimirovich
  • Simbirtsev Andrej Semenovich
  • Klimov Nikolaj Anatolevich
  • Petrov Aleksandr Vladimirovich
  • Karasev Maksim Mikhajlovich
RU2630647C1
C3b ANTIBODIES AND METHODS FOR PREVENTION AND TREATMENT OF COMPLEMENT-RELATED DISORDERS 2008
  • Van Lokeren Kampagne Menno
RU2473563C2
AFFINITY-MATURED CRIG VERSIONS 2009
  • Sidkhu, Sachdev, S.
  • Li, Bin
  • Van Lokeren Kampagne, Menno
  • Vismann, Kristian
RU2553517C2
METHOD FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION 2010
  • Shveble Khans-Vilgelm
  • Dadler Tomas A.
  • Tedford Klark I
  • Perent Dzhejms B.
  • Demopulos Gregori A.
RU2600876C2
METHOD FOR OBTAINING TRANSGENIC ANIMAL 1990
  • Uajt Dehvid Dzhejms Grekhem
  • Vill'Jams Alan Frederik
RU2252533C2
METHOD FOR TRANSPLANTATION OF ANIMAL CELL, TISSUE OR ORGAN FOR A RECIPIENT AND PREPARATION FOR ITS IMPLEMENTATION 1990
  • Uajt Dehvid Dzhejms Grekhem
  • Vill'Jams Alan Frederik
RU2195956C2
DNA MUTAGENESIS BY DISORDERED FRAGMENTATION AND SECONDARY ASSEMBLY 1995
  • Villem P.S. Stemmer
  • Andreas Krameri
RU2157851C2
ANTIBODIES AGAINST FACTOR D AND THEIR USE 2018
  • Song, Wenchao
  • Zhou, Lin
  • Sato, Sayaka
  • Miwa, Takashi
  • Gullipalli, Damodar
  • Golla, Madhu
RU2799044C2
FVIII MODIFICATION TREND SITE 2005
  • Pehn Klark Kv.
  • Merfi Dzhon I.
  • Mej Bejsong
  • Strauss Dzhonatan S.
  • Tzhandra Khendri
  • Chen Zhianmin
  • Barnett Tomas
  • Tang Liang
  • Vang Dekvian
RU2423380C2

RU 2 238 322 C2

Authors

Farris Timoti Charlz

Kharrison Richard Aleksandr

Dates

2004-10-20Published

1997-03-04Filed